Half Year 2026 Stratec Se Earnings Call Transcript
Key Points
- Stratec SE (XTER:SBS) reported a strong Q2 performance, significantly narrowing the year-on-year sales and earnings gap by the end of H1 2026.
- The system business showed robust growth, with revenues increasing by 15.4% on a constant currency basis, driven by strong demand in immunoassay, molecular diagnostics, and immunohematology.
- The company demonstrated resilience in its business model, maintaining adjusted EBIT margin close to prior year levels despite weak consumables, showcasing cost discipline.
- Free cash flow improved dramatically to EUR23.5 million in H1 2026, compared to a negative EUR14.7 million in the prior year, driven by reduced accounts receivable and lower tax payments.
- Stratec SE (XTER:SBS) confirmed its 2026 guidance, expecting a strong year-end business with Q4 contributing 30-33% of annual revenues, and maintained mid-term targets of 6-8% top-line growth and at least 13% adjusted EBIT margin by 2028.
- Consumables, particularly maintenance parts and spares, were exceptionally weak in H1 2026, with service parts and consumables revenue declining 11.9% on a constant currency basis due to customer inventory optimization.
- Overall revenue declined by 5.1% (3.3% on a constant currency basis) in H1 2026, impacted by temporary effects and a high comparison base in the development business.
- The product mix shift away from high-margin service parts and consumables negatively impacted the adjusted EBIT margin, which fell to 6.9% from 7.2% in the prior year.
- The company faces significant supply chain challenges, including materially increasing lead times and prices for electronics, with no price guarantees from suppliers, posing a risk to margins and delivery.
- The MDx market remains saturated and flat, with run rates still below pre-COVID levels, and the company expects only a slight recovery, which could limit growth in the near term.
Good afternoon, good morning to everyone joining us today for our H1 2026 financial results conference call. With me and the hosts of the presentation today are Marcus Wolfinger, CEO of Stratec; as well as our CFO, Tanja Buechel. Please be aware that this conference is being webcast live, and you can download the slides either from the webcast or from our website.
Before we start, please allow me also to draw your attention to our safe harbor statement, which is on page slide of the presentation.
And now, without further ado, my pleasure to hand over to Marcus.
Thanks, and good afternoon. Good morning, everyone. Welcome to our presentation. Let me briefly walk you through the highlights, achievements, and to a certain degree, the challenges for the remainder of the year. As you have all seen, we have significantly improved performance in Q2, which actually helped us to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
